Airija -
anglų -
HPRA (Health Products Regulatory Authority)
etoposide
accord healthcare limited - etoposide - concentrate for soln for inf - 20 mg/ml - etoposide
Airija -
anglų -
HPRA (Health Products Regulatory Authority)
vepesid 100 milligram capsules, soft
bristol-myers squibb (holdings) limited - etoposide - capsules, soft - 100 milligram - podophyllotoxin derivatives
Airija -
anglų -
HPRA (Health Products Regulatory Authority)
vepesid 50 mg milligram capsule
bristol-myers squibb (holdings) limited - etoposide - capsule - 50 mg milligram - podophyllotoxin derivatives
Airija -
anglų -
HPRA (Health Products Regulatory Authority)
etoposide 20 mg/ml concentrate for soln for inf
cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).
Malta -
anglų -
Medicines Authority
etoposide 20mg/ml concentrate for solution for infusion (100mg/5ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
Malta -
anglų -
Medicines Authority
etoposide 20mg/ml concentrate for solutionn for infusion (5ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
Malta -
anglų -
Medicines Authority
etoposide 20mg/ml concentrate for solutionn for infusion (10ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
Malta -
anglų -
Medicines Authority
etoposide 20mg/ml concentrate for solutionn for infusion (25ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
Malta -
anglų -
Medicines Authority
etoposide 20mg/ml concentrate for solutionn for infusion (50ml vial)
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents
Didžioji Britanija -
anglų -
MHRA (Medicines & Healthcare Products Regulatory Agency)
vepesid 50mg capsules
neon healthcare ltd - etoposide - oral capsule - 50mg